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Loss of retinal ganglion cells (RGCs) is a leading cause of blinding conditions. The purpose of this study was
to evaluate the effect of extracellular L-lactate on RGC survival facilitated through lactate metabolism and ATP
production. We identified lactate as a preferred energy substrate over glucose in murine RGCs and showed
that lactate metabolism and consequently increased ATP production are crucial components in promoting
RGC survival during energetic crisis. Lactate was released to the extracellular environment in the presence of
glucose and detained intracellularly during glucose deprivation. Lactate uptake andmetabolism was unaltered
in the presence and absence of glucose. However, the ATP production declined significantly for 24 h of
glucose deprivation and increased significantly in the presence of lactate. Finally, lactate exposure for 2 and
24 h resulted in increased RGC survival during glucose deprivation. In conclusion, the metabolic pathway of
lactate in RGCs may be of great future interest to unravel potential pharmaceutical targets, ultimately leading
to novel therapies in the prevention of blinding neurodegenerative diseases, for example, glaucoma.
© 2019 Elsevier Ltd. All rights reserved.Introduction
Retinal ganglion cell (RGC) loss is a major cause of
blinding inner retinal conditions, such as glaucoma.
RGCs and their axons constitute the optic nerve and
are crucial in transmitting neuronal signals from the
eye to the brain to provide visual interpretation.
Hence, compromised RGC survival subsequently
results in progressing visual field loss and in advanced
cases of blindness [1,2]. Thus, further understanding
of RGC homeostasis is essential for the development
of novel treatment strategies to prevent inner retinal
neurodegenerative conditions.
The axons of RGCs are unmyelinated within the
retina and therefore only protected by the surrounding
macroglial cells, primarily the Müller cells. Therefore, it
has been proposed that the glia–neuron partnership is
important for RGCsurvival [3–5]. In linewith this,Müllerr Ltd. All rights reserved.cells have been shown to secrete various neuropro-
tective factors, such as energy substrates, growth
factors, neutrophins, and prostaglandins [4,6,7], which
are known to further facilitate RGC survival. In addition,
co-culture studies have identified that the mere
presence of Müller cells is a fundamental factor for
sustaining RGC survival [8–12]. Recent studies have
identified lactate as a neuroprotective molecule. In this
context, lactate has been shown to act as an essential
energy fuel to maintain neuronal survival and functions
[13–19]. Similar to these studies, we and others have
recently discovered that Müller cells secrete lactate
[20–23] and that extracellular lactate is an essential
modulator of Müller cell survival and function [20].
Likewise, we suggest that extracellular lactate concen-
trations may be equally important for RGC survival.
In general, the retina is a highly metabolic organ
with up to 10-fold higher concentrations of lactate (5–Journal of Molecular Biology (2019) 431, 1878–1888
1879Lactate-Mediated Protection of RGCs50 mmol/L) compared to other body tissues and blood
[24–26]. Although lactate is primarily known to be
produced during anaerobic conditions, retinal cells
have also been shown to produce lactate during
sufficient oxygen availability (the Warburg effect)
[21,27]. In a recent study,we demonstrated that lactate
was preferred over glucose inMüller cells as an energy
source [20], thereby challenging the general assump-
tion of lactate being merely a metabolic waste
molecule. Moreover, neuroprotective responses to
extracellular lactate have been reported in the brain
concerning preservation of long-termmemory [28] and
protecting against traumatic brain injury [29,30]. The
novel neuroprotective features of lactate in the brain
are, however, still in the process of being unraveled,
and we propose that similar beneficial features may
also be identified in the retina.
In thepresent study,weaimed to investigate possible
neuroprotective effects of extracellular lactate in
primary murine RGC cultures and to establish whether
lactate is metabolized, securing survival of the RGCs
and thereby protecting the RGCs from a toxic insult
mimicked by glucose deprivation.Materials and Methods
Cell cultures: Primary RGCs and Müller cells
Murine RGCs and Müller cells were cultured from
dissected retinas of neonatal mice (C57BL/6J, Charles
River, Germany and/or Janvier, France) at postnatal
days 7–8. The mice were euthanized by cervical
dislocation, and the eyes were enucleated into D-PBS
(cat. no. 14287080; Gibco). Retinas were dissected
under a microscope (Leica S4E) using a forceps and
curved scissor. The simultaneous purification of RGCs
and Müller cells was obtained according to the method
described by Skytt et al. [8]. In experiments where the
Müller cells alone were purified, dissected retinas were
incubated for 30 min in DMEM (21885025; Gibco)
supplemented with collagenase (65 U/mL) and trypsin
(0.25%). The cells were after incubation rinsed thrice in
DMEMcontaining 10% fetal bovine serum (10270-106;
Gibco) to terminate the digestion. The digested retinas
were mechanically dissociated by gentle trituration
through an 18-G needle producing a suspension of
tissue micro-aggregates and single cells. Cells were
seeded in tissue culture plates (TPP) at a density of
0.7–1 retina/cm2.Müller cells weremaintained at 37 °C
in a humidified atmosphere with 5% CO2 and cultured
in DMEM containing glucose (1.0 g/L), pyruvate
(1 mM), L-alanyl-glutamine (3.97 mM), supplemented
with penicillin (90 units/mL) and streptomycin (90 μg/
mL), and 10% fetal bovine serum. Two days after
purification, the plates were washed vigorously with
media to detach tissue aggregates and non-adherent
cells. The cells were kept in culture for 7–14 days withculture medium changed twice a week. Aggregates
and debris were removed by forcible resuspension of
medium onto the cell monolayer. Cell cultures of Müller
cells were approximately 80%–90% confluent when
used for experiments.
RGCs were kept in culture in a 37 °C humidified
atmosphere with 10% CO2 for 7 days in a ND-growth
mediumwith change of one third of themedium volume
on the third day in culture and 1 day prior to
experiments. The RGCs were seeded in TPP plates
at a density of 150,000 cells/cm2. The ND-growth
culture medium was formulated as described by Skytt
el al. [8]. Briefly, neurobasal medium (cat. no.
12349015; Gibco) was mixed in equal amounts with
DMEM high-glucose medium consisting of 25 mM
glucose (31966047; Gibco) with the addition of
penicillin (1000 units/mL), streptomycin (1000 μg/mL),
insulin (0.5 μg/mL), sodium pyruvate (1.5 mM), 3,3,5-
Triiodo-L-thyronine (40 ng/mL), L-glutamine (3.7 mM),
B27 supplement (1×; Gibco), and trace elements B
(1×; Cellgro, USA). Themediumwas also supplement-
ed with a Sato stock consisting of transferrin (to reach
100 μg/mL in media), BSA (to reach 100 μg/mL in
media), progesterone (to reach 63 ng/mL in media),
putrescine (to reach 16 μg/mL in media), and sodium
selenite (to reach 40 μg/mL in media). In addition, NAC
(5 μg/mL), biotin (10 ng/mL), BDNF (50 ng/mL, 248-
BD-025; R&D Systems, UK), CNTF (10 ng/mL, 257-
NT-010; R&D Systems), FGFb (10 ng/mL, PMG0034;
Gibco), and forskolin (4,2 μg/mL) were added to the
medium. For treatment, neurobasal (0050128DJ;
Gibco) and DMEM without glucose (A14430; Gibco)
were used for glucose deprivation and in experiments
with 6 mM glucose, a stock solution of 2.5 M glucose
was used to obtain the desired concentration of 6 mM
glucose. The specific concentration of 6 mMof glucose
was chosen to represent physiological systemic
concentrations of glucose in humans.
Retinal explant cultures
Eyes were removed immediately postmortem from 8
to 10 weeks old C57Bl/6J mice (Janvier, France).
Whole tissue retinas were taken out in one piece by
using a needle to punctuate the eye and a curved
scissor to remove the anterior part of the eye. Two
forcepswere used to detach the sclera of the remaining
part of the eye, and fine brushes were used to gently
move the explant if needed as described previously
[31,32]. The retinas were orientedwith the ganglion cell
layer facing upward. One retina was acknowledged as
a biological sample and divided into four retinal
explants, which accounted for a specific time point.
Retinal explants were cultured directly in cell culture
inserts in TPP plates and treated with control media
(6 mM glucose) and treatment media (0 mM glucose)
at day 0 (day of setup). The explants were subse-
quently cultured for 2 h, 24 h, 3 days, and 7 days in a
humidified incubator with 5% CO2 at 37 °C.
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RGCs, Müller cells, and retinal explants were
treated with medium (DMEM A1443001 for Müller
cells, neurobasal 0050128DJ for retinal explants)
containing 6 mM glucose or 0 mM glucose for 2 and
24 h at 37 °C in respectively 10% CO2 for RGCs and
5% CO2 for Müller cells and retinal explants. The
retinal explants were additionally treated for 3 and 7
days. The media was collected and kept at −80 °C
until measurements were performed. The lactate
measurements were determined by colorimetric
detection employing a Lactate Assay Kit (Sigma-
Aldrich, MAK064-1KT) according to the manufac-
ture's protocol and absorbances were read at
570 nm.
Lactate dehydrogenase assay
Lactate dehydrogenase (LDH) cell viability kit
(Takara Bio, Inc., Shiga, Japan) was used to
quantitatively assess retinal tissue viability. Retinal
explants were treated according to previous de-
scribed treatments for 2 h, 24 h, 3 days, and 7 days.
The media was collected and LDH release was
determined as measurement for viability by the
absorbance readings at 490 nm. Tissue viability
was calculated based on the absorbance readings
of the collected media.
Metabolic labeling studies
Cell culturemediumwas changed 1 day prior to the
experiments. To examine lactate metabolism in the
primary mice RGCs, the cells were incubated for 2 h
at 37 °C in DMEM in the presence (6 mM) or
absence (0 mM) of unlabeled D-glucose. At the
start of treatment (time = 0 h), the cells were spiked
with an aliquot of sodium L-[U-13C]-lactate (98%
[13C] enriched; CLM-1579-PK; Cambridge Isotopes
Laboratories Inc., MA, USA) to a final concentration
of 10 mM. To investigate the metabolism of glucose
in comparison with lactate, treatment with 6 mM
labeled D-glucose (D-[13C]-glucose (99%) [13C]
enriched; CLM-1396-10; Cambridge Isotopes Labo-
ratories Inc., MA, USA), with and without spiking of
unlabeled sodium L-lactate to a final concentration of
10 mM, was performed. After the 2-h treatment, the
medium was collected and cells were rinsed twice
with ice-cold phosphate-buffered saline. Subse-
quently, RGCs were extracted in 70% ethanol and
centrifuged (20,000g for 20 min at 4 °C) to separate
the soluble extract (supernatant) from insoluble
components (pellet). Protein content was determined
in the pellets via the BCA protein assay kit (Sigma-
Aldrich, USA). Media and cell extracts were both
lyophilized and reconstituted in water for further
biochemical analysis by gas chromatography
coupled to mass spectrometry. Spectrometric anal-ysis was performed as previously described [33].
Briefly, extract samples were adjusted to pH 1–2with
HCl and evaporated to dryness under nitrogen flow.
Analytes were extracted into an organic phase (96%
ethanol/benzene) followed by derivatization with
14%DMF/86%MTBSTFA with amodified procedure
from Mawhinney et al. [34]. Standards containing
unlabeled metabolites of interest and cell extracts
were separated and analyzed in a gas chromato-
graph (Agilent Technologies 7820A chromatograph,
J&W GC column HP-5MS, parts no. 19091S-433)
coupled to a mass spectrometer (Agilent Technolo-
gies, 5977E). The isotopic enrichment of the metab-
olites of interest was corrected for natural abundance
of 13C using the unlabeled standards and calculated
according to Biemann [35]. Data are presented as
labeling (%) of M + X, where M is the mass of the
unlabeledmolecule andX is the number of labeledC-
atoms in a given metabolite.
ATP assay
Primary murine RGCs were treated for 2 and 24 h
in the presence and absence of 6 mM glucose with
the addition of 10 mM L-lactate. Intracellular ATP
concentrations were measured using the Biolumi-
nescent Somatic Cell Assay Kit (FLASC-1KT;
Sigma-Aldrich) according to the manufacturer's
protocol. A luminescence counter (Spectramax;
Molecular Devices) was used to measure the
luminescence signal from the samples added in
black 96-well plates. Adenosine 5′-triphosphate
standards were used to create an ATP calibration
curve for the assay. ATP amounts were calculated
using the standard and corrected for amount of
protein, which was determined by the BCA protein
assay kit (Sigma-Aldrich).
MTT viability assay
Müller cell survival was determined by the color-
imetric method, MTT (3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide), measuring
the ability of viable cells to reduce MTT measured
at the absorbance 560 nm. The RGC cultures were
incubated in medium with the presence or absence
of glucose and/or L-lactate for 2 and 24 h. Subse-
quently, the cells were incubated with 12 mM MTT
solution for 1 h at 37 °C and the cells were solubilized
in 10% SDS and 0.01 M HCl. Eighteen hours later,
the absorbance was measured at 560 nm. The
background readings (blank wells with medium,
MTT solution, and solubilization buffer) were sub-
tracted from the absorbance readings of the treated
wells to obtain an adjusted absorbance reading
representing cell viability. Finally, the readings were
divided by the adjusted absorbance readings of
untreated (control) cells to obtain a percentage of
cell survival.
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Data were analyzed using GraphPad software
(GraphPad Prism version 7.0). Statistical comparisons
between two groups were analyzed by unpaired two-
tailed t test. Statistical comparisons between several
groupswere analyzed by one-wayANOVA followed by
Tukey's multiple comparison post-test. Survival data
were analyzed using two-way ANOVA (Tukey's
multiple comparisons post hoc test). In all analyses,
p b 0.05 were considered to be statistically significant.
Both biological and technical replicates were used to
enable sufficient statistics. “Biological replicates” indi-
cate a pool of biologically different retinas, which were
used to make the final Müller cell and RGC purification
for one given experiment. Technical replicates indicate
the amount of times a given measurement was
performed.Results
Primary Müller cells and RGCs release lactate to
the extracellular environment
Extracellular lactate was quantified in treatment
media (initially lactate free) after 2 and 24 h of
treatment with 6 mM glucose and 0 mM glucose.
In Müller cells, extracellular lactate levels decreased
from 7.9 ± 1.5 to 0.9 ± 0.04 nmol/μL during glucose
deprivation for 2 h (p b 0.05). The same phenomenon
was established after 24 h of glucose deprivation,
where lactate release decreased from 54.7 ± 1.7 to
1.1 ±0.04 nmol/μL (p b 0.0001). In the presence of
6 mMextracellular glucose, lactate release fromMüller
cells increased significantly over time from 2 and 24 h
(p b 0.0001) (Fig. 1a). The same was seen for RGCs,
where lactate release increased from 6.9 ± 2.4 to
57.7 ± 6.8 nmol/μL (p b 0.0001) from 2 and 24 h.
When RGCswere deprived of glucose for 24 h, lactate
release from the RGCs decreased to 19.3 ± 2.3 nmol/
μL (p b 0.001) (Fig. 1b). In retinal explants, lactate
release increased over time when the explants were
supplemented with glucose. Glucose-deprived ex-
plants did not release any significant levels of lactate
(Fig. 1c). Time-dependent retinal degeneration was
confirmed through a commercialized viability assay
(LDH assay). Glucose deprivation for 24 h and 3 days
accentuated the time-dependent decrease in retinal
viability to 5.1% ± 0.8% and 5.2% ± 1.6%, respective-
ly (p b 0.05) (Fig. 1d).
Lactate is taken up and metabolized by RGCs
To establish whether lactate was metabolized in
RGCs, incubations with labeled [U-13C]-lactate were
performed and compared with the metabolism of
labeled [U-13C]-glucose.Metabolism was measured by incorporation of
carbon into various metabolic intermediates. The
incorporation of 13C from [U-13C] glucose in to lactate
(p b 0.05), alanine (p b 0.05), alpha-ketoglutarate
(p b 0.05), aspartate (p b 0.05), glutamate (p b 0.05),
succinate (p b 0.05), malate (p b 0.05), and fumarate
decreased during simultaneous addition of 10 mM of
unlabeled lactate compared to treatment with [U-13C]
glucose alone (Fig. 2a–c). Incorporation of 13C from
[U-13C] lactate remained unaltered by the addition of
unlabeled glucose (Fig. 2d–f).
Lactate metabolism increases ATP production
in RGCs
To correlate the effect of lactatemetabolism in RGCs
with the energy status of the cell, total ATP levels were
measured. ATP levels remained stable within 2 h of
treatment with lactate in glucose supplemented RGCs
and glucose-deprived RGCs (Fig. 3a–c). Furthermore,
glucose deprivation in itself did not have an effect of the
total amount of ATPwithin 2 h, whereas after 24 h, total
ATP levels decreased significantly to 81% ± 4%
(p b 0.01) (Fig. 3d). No changes of total ATP were
seen in response to the addition of lactate in glucose
supplemented RGCs (Fig. 3e).
The presence of 10 mM of lactate for 24 h of
glucose deprivation increased total ATP levels to
148% ± 18% (p b 0.05) (Fig. 3f).
The presence of extracellular lactate increases
survival of glucose-deprived RGCs
RGCviabilitywasdetermined to investigate theeffect
of lactate metabolism and increased ATP on overall
survival of RGCs. Cell viability remained unaffected in
glucose supplemented RGCs within 2 and 24 h of
treatment with 10 and 20 mM L-lactate (Fig. 4a and b).
In glucose-deprived RGCs, however, the presence of
10 mMof extracellular L-lactate increased survival from
71% to 96% after 2 h (p b 0.01) and from 55% to 72%
after 24 h (p b 0.01) (Fig. 4a and b). The presence of
20 mM of extracellular L-lactate increased survival to
97% after 2 h (p b 0.01) (Fig. 4a).
Glucose deprivation in itself decreased RGC viability
within 2 and 24 h to 71% (p b 0.01) and 55%
(p b 0.001), respectively. This effect was, however,
abolished through the addition of 10 and 20 mM L-
lactate after both 2 and 24 h.Discussion
Promoting RGC survival is pivotal in preventing
blinding inner retinal neurodegenerative diseases.
The aim of this study was to elucidate the potential
role of lactate in RGC survival. We showed that
lactate is released from isolated murine Müller cells
and that extracellular lactate is taken up by RGCs to
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Fig. 1. Lactate release inmurineMüller cells (a), RGCs (b), and retinal explants (c). Cellswere treatedwith andwithout 6 mM
glucose for 2 and 24 h for cells, and additionally 3 days and 7 days for retinal explants. In the presence of glucose, lactate
release increased over time in both Müller cells and RGCs, as well as retinal explants. During glucose deprivation, lactate
release decreased in both Müller cells and RGCs, as well as retinal explants. Furthermore, glucose deprivation accentuated
retinal degeneration over time (d). Stars above columns indicate comparison to controls, respectively, “6 mMGLC” and “0 mM
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*p b 0.05, ***p b 0.001, ****p b 0.0001. Statistics: two-way ANOVA (Tukey's multiple comparisons test).
1882 Lactate-Mediated Protection of RGCssecure survival of the cells during normal physiolog-
ical conditions and to aid in neuroprotection of the
RGCs during pathophysiological conditions, such as
glucose deprivation. Overall, our study revealed
novel features of lactate. Lactate was shown to be a
preferred energy substrate compared with glucose,
and the metabolism of lactate resulted in increased
ATP production and survival of RGCs.
Generally, it is acknowledged that during sufficient
oxygen and glucose supply, neuronal glucose metab-
olism will favor oxidative phosphorylation for energy(ATP) production. However, retinal cells, including
retinal neurons, are known to be primarily glycolytic
[21,22,27,36–39]. Recently, Lindsay et al. [40] pro-
posed that murine Müller cells display pyruvate kinase
(PK) deficiency by expressing limited PK isoforms,
indicating that the conversion of pyruvate from
phosphoenolpyruvate, and ultimately lactate produc-
tion in Müller cells, is limited. In opposition to this, we
established that murine Müller cells were able to
produce and release lactate in abundant and physio-
logically relevant amounts. Moreover, we also
1883Lactate-Mediated Protection of RGCsconfirmed this previously by measuring increased
extracellular lactate levels and an increase in the
extracellular acidification rate during satisfactory glu-
cose supply for 24 h in a human Müller cell line, MIO-
M1 cells, supporting the assumption of preferred
glycolysis in Müller cells [41]. Thus, although the
expression of PK might be limited, the activity of the
enzyme in Müller cells seems to be intact. Neverthe-
less, during insufficient glucose supply, theMüller cells
will shift to oxidative phosphorylation [42], and the
Crabtree effect [43]. This effect is commonly seen in
cancer cells and resembles metabolic effects of5
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1884 Lactate-Mediated Protection of RGCsTaken together, these findings combined with the
verified expression of the lactate transporters, mono-
carboxylate transporters 1 and 4 in the inner retina [44]
could imply the presence of a potential lactate-shuttle
from Müller cells to RGCs and vice versa. Future
studies comprising Müller cell–RGC co-cultures com-
bined with monocarboxylate transporter blockage will
be able to confirm this. The aspect of lactate shuttling
between glia cells and neurons has previously been
described as the lactate shuttle hypothesis presentedFig. 2. [U-13C]-glucose and [U-13C]-lactate metabolism in RG
[U-13C]-lactate (d–f) for 2 h. At the end of treatment, cell extrac
coupled to mass spectrometry for determination of the percen
13C labeling in M + 3 for lactate and alanine (a + d), in M + 2
(b + e), as well as in the subsequent turn of the TCA cycle,
substrates of glycolysis and TCA cycle decreased in the pres
lactate compared to the presence of [U-13C]-glucose alone. T
stable despite the addition of unlabeled glucose. This indic
glucose. Panel g provides a metabolic overview of labeling patt
to pyruvate, which enters the mitochondria. Pyruvate is further
oxaloacetate yields citrate. White circles depict the mass (M) of
atoms in a metabolite. Measurement was performed on alpha-
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metabolism or direct formation of pyruvate from [U-13C]-lactate
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whereM equals the mass of the unlabeled molecule and X is th
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presented as mean ± S.E.M of four biological replicates. *p bby Pellerin and Magistretti et al. [45–47]. The
hypothesis postulates that neurons are predominantly
oxidative and astrocytes are mainly glycolytic, corre-
sponding with reported elevated amounts of mitochon-
dria in RGCs [48] and our previous findings regarding
Müller cells [41]. The purpose of lactate-shuttle in the
retina would be to ensure optimal levels of retinal
lactate to avoid lactate acidosis, yet still maintain retinal
structure and function. This has previously been
investigated in single cells of the retina, namely, MüllerCs. The cells were treated with [U-13C]-glucose (a–c) and
ts were collected and analyzed using gas chromatography
tage distribution of 13C-labeled metabolites presented by
for metabolites obtained after a first run of the TCA cycle
M + 4 (c + f). The incorporation of carbon in intermediate
ence of labeled [U-13C]-glucose combined with unlabeled
he incorporation of carbon from [U-13C]-lactate remained
ated that lactate may be preferentially metabolized over
erns and metabolism. Glucose and lactate are metabolized
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. During experiments, only one labeled substrate was used
se or lactate. Data are presented as labeling (%) of M + X,
e number of labeled C-atoms in a metabolite. Lac, lactate;
mate; suc, succinate; mal, malate; fum, fumarate. Data are
0.05. Statistics: unpaired t test.
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Fig. 4. Survival of glucose-deprived RGCs increases in response to lactate after both 2 and 24 h of treatment. The cells
were treated with and without 6 mM glucose combined with 10 and 20 mM of L-lactate in the media for 2 and 24 h. An MTT
assay was performed to assess survival. After 2 h, the presence of 10 and 20 mM of L-lactate increased survival of the
glucose-deprived RGCs significantly (a). During glucose deprivation for 24 h, the presence of 10 mM of L-lactate increased
survival of the glucose-deprived RGCs significantly (b). No significant differences of survival were seen in glucose
supplemented RGCs. Data are presented as mean percentage of cell viability ± S.E.M of 6-7 biological replicates with four
technical replicates. *p b 0.05, ***p b 0.001, ****p b 0.0001. Statistics: two-way ANOVA (Tukey'smultiple comparisons test).
1885Lactate-Mediated Protection of RGCscells [20]. However, to our knowledge, this has not
been shown in retinal tissue; thus, we measured total
lactate release from retinal explants in response to
glucose deprivation and revealed that lactate release
was limited. This could imply that the tissue utilizes
internal energy sources and does not have any excess
metabolic substrates to generate and/or secrete
lactate from. The strength of thismodel system reflects
the use of adult mice compared to pubs utilized in the
isolated cell cultures. A future perspective would be to
use even older mice to mimic age-related retinal
degeneration more thoroughly. Regardless, our study
does confirm time-dependent degeneration of retinal
explants from 8- to 10-week-old mice. During intact
levels of extracellular glucose, lactate release from
retinal explants increased over time. This may
potentially aid in facilitating viability of the tissue
explant in spite of time-dependent retinal degenera-
tion. Although it is evident that the explants degenerate
over time, independently of glucose availability,
glucose deprivation accelerates this process com-
pared to glucose-supplemented retinal explants. In the
end, a compensatory increase in lactate production
may, however, also be toxic by altering pH. Thus, a
tight regulation of extracellular lactate levels is required
andmay be obtained through lactate shuttle. The glial–
neuronal lactate shuttle hypothesis is an ongoing
debate [47,49], and the present study has addedmore
information to this discussion. While the most wide-
spread belief has been that glucose is predominantly
metabolized in neurons [49], our study has shed light
on the possible preference of lactate as an energysubstrate for RGCs—at least in vitro. Thus, the lactate
shuttle in the inner retina may involve a shuttle of
lactate from Müller cells to fuel the RGCs, especially
during critical conditions such as sparse glucose
supply. Our viability studies performed on isolated
RGCs confirm this protective effect of extracellular
lactate on RGC survival during glucose deprivation.
Hence, no significant difference in survival was
established when comparing 6 mM glucose supple-
mented RGCs with lactate-added glucose-deprived
RGCs.
Interestingly, during glucose deprivation, the con-
centrations of released lactate from RGCs were still
relatively high of approximately 17 nmol/μL, indicating
thatRGCsmayalso utilize othermetabolic pathwaysor
other metabolic substrates as energy source. The
neurobasal medium used in this study contain numer-
ous branch-chained amino acids, such as serine,
threonine, cysteine, methionine, and alanine, which
can all be metabolized to pyruvate and thereby lactate.
In this context, it may also be that the lactate shuttle in
this case is not unidirectional and that RGCs may also
metabolically provide Müller cells with lactate. In line
with this, lactate has recently been shown to be
metabolized in Müller cells [20,40], and it has also
been proposed that other cells of the retina, such as
photoreceptor cells, may facilitate the Müller cells with
lactate [40,50]. Future studieswith co-cultures ofMüller
cells and RGCs will elucidate mechanisms of lactate
shuttle in the inner retina. Nevertheless, it can be
speculated that RGCs may re-use their own pool of
lactate or additional lactate released fromMüller cells to
1886 Lactate-Mediated Protection of RGCsthe extracellular environment. In summary, we are the
first to show that RGCs actually metabolize lactate and
perhaps even prefer lactate metabolism for energy
production, since the addition of unlabeled glucose did
not have any effect on the total labeling in metabolic
intermediates. This novel finding challenges previous
assumptions of the use of lactate to spare glucose for
neurons [49,51], since RGCs are rather utilizing lactate
than glucose as an energy substrate. However, it may
be different for other neuronal cells of the retina. In this
context, we have previously revealed that Müller cells
are able tomaintain their glycogen deposits over time in
the presence of lactate [20], thereby potentially saving
glucose as glycogen for other neighboring neurons of
the retina. Regardless, preferable lactate consumption
in the RGCs correlates nicely with an increase in ATP
levels, thereby linking lactate metabolism with in-
creased survival of RGCs. These findings differed
from the study performed byWinkler et al. [21] in which
ATP content of RGC-5 cells remained unaltered in
response to 10 mM of lactate in the media. The
contradicting findings can be explained by the nature
of RGC-5 cells, which have been shown to possess
mice photoreceptor characteristics instead of the
presumed RGC [52,53]. Thus, the use of primary
murineRGCs in this study is of great importance. In our
case, the presenceof extracellular lactate protected the
RGCs from dying of glucose deprivation, identifying a
potential lactate-mediated neuroprotection of the
RGCs through increased metabolism and ATP pro-
duction. Our study may suggest that compromised
lactate-facilitated neuroprotection may potentially be
involved in the development of inner retinal diseases, in
which the RGCs are dying. One of the most predom-
inant inner retinal diseases is glaucoma, and a recent
study revealed that patients with normal tension
glaucoma had lower systemic blood lactate levels
comparedwith age-matched healthy controls [54]. This
supports the idea of a potential involvement of lactate in
retinal neurodegeneration, which may consequently
alter visual perception.
In conclusion, the present study revealed that high
concentrations of extracellular lactate are crucial for
RGC survival during sparse glucose supply. Albeit,
future studies are necessary to explore the beneficial
effects of lactate on neuronal survival in ex vivo and
in vivo models of retinal neurodegeneration.Acknowledgments
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